Skip to main content
Clinical Trials/IRCT20201212049686N1
IRCT20201212049686N1
Completed
Phase 3

Study of the difference of renal complications in single and double daily dose of Amikacin in patients with neonatal sepsis in Imam Khomeini Hospital in Tehran: A double blind clinical trial

Tehran University of Medical Sciences0 sites90 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
90
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients with neonatal sepsis
  • Parental consent to participate in the study

Exclusion Criteria

  • incomplete treatment
  • parental dissatisfaction with continuing treatment
  • evidence of asphyxia
  • renal abnormalities at birth

Outcomes

Primary Outcomes

Not specified

Similar Trials